Tumor genetics for personalized pediatric cancer treatment
Part of Blood & lymphatic, Cancer clinical trials.
This trial studies the genetic makeup of your tumor to find personalized treatment options, especially if standard treatments have not worked. It aims to match you with experimental treatments that target your cancer's specific changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with cancer (solid tumor or leukemia) when you were 25 or younger.
- Your cancer must have come back after treatment or not responded to standard treatment.
- You must have a tumor sample that is either recent (within the last 3 months) or planned to be taken (through biopsy, surgery, or blood draw).
- You must be considered for an experimental treatment or early-phase clinical trial.
- You need to be in good enough health to join a clinical trial (expected survival over 3 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks for the specific DNA or tumor changes in your cancer and then matches you to a targeted drug plan. It’s meant for people with early cancer that has not already been treated in this study.
This trial studies how personalized (tailored) genetic testing can help guide care for children with cancer. It may help match treatment choices to each child’s genetic risk, and it includes optional return of germline (inherited) test results.
This trial uses a new testing platform to analyze the genes and proteins in your tumor, aiming to find the most effective treatments for people with cancer that has come back, is not responding to treatment, or has spread. It is designed for both children and adults with any type of blood cancer or solid tumor.
This early-phase trial tests a treatment plan that uses results from genetic testing of your tumor to choose the best targeted therapy. It may help people whose cancer has come back or does not respond to standard treatment by matching treatment to specific tumor changes.
This early study uses tumor tissue (or bone marrow from blood cancers) and performs lab tests to see which cancer drugs may work better for each person. It also collects genetic information from blood or a saliva swab to help understand why cancers respond differently.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.